Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2012
06/27/2012CN102516229A Fluorescent probe for detecting histidine, precursor thereof and preparation methods of fluorescent probe and precursor
06/27/2012CN102516228A 1'-(N-alkyl-1, 8-naphthalimide)-3'-(substituted phenyl)pyrazoline fullerene compound and its preparation method
06/27/2012CN102516227A Method for flocculating, decolorizing, separating and purifying nicotine
06/27/2012CN102516226A Method for distilling and refining nicotine circularly and nicotine distilling and absorbing device
06/27/2012CN102516225A Synthesis of novel medicine intermediate (R)-3-phenyldicarboximidopiperidine hydrochloride
06/27/2012CN102516170A Amide derivatives
06/27/2012CN102516168A Ciprofluoroquinolone C3/C7 dithizone Schiff base, preparation method and application thereof
06/27/2012CN102516161A Pyridine and pyrimidine derivatives as mglur2 antagonists
06/27/2012CN102516153A 5-fluoroindole-2-one-3-carbamide compounds, preparation method thereof and application thereof
06/27/2012CN102516115A Novel compounds as antagonists or inverse agonists at opioid receptors
06/27/2012CN102516003A Methods for the purification of radiolabelled products using a solid-support scavenger
06/27/2012CN102512424A Compositions and methods relating to novel compounds and targets thereof
06/27/2012CN102512380A Freeze-dried powder injection with omeprazole sodium as active component and preparation method thereof
06/27/2012CN101973934B 1,5-disubstituted aryl-1,4-pentadiene-3-ketoxime ether compound and preparation method thereof and insecticidal activity application
06/27/2012CN101903339B Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
06/27/2012CN101790522B Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
06/27/2012CN101781299B One-pot synthesis method for key intermediate of carbostyril medicaments
06/27/2012CN101679241B Prolinamide derivatives as NK3 antagonists
06/27/2012CN101595096B Substituted carbinol compound
06/27/2012CN101563330B Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators
06/27/2012CN101547976B Anthrapyridone compound, salt thereof, magenta ink composition containing the same, and colored body
06/27/2012CN101506162B Substituted isoindoles as bace inhibitors and their use
06/27/2012CN101454285B Oxadiazole derivatives as comt inhibitors
06/27/2012CN101434599B Mixed metal complex emitting white light and preparation thereof
06/27/2012CN101103022B New carboxylic acid amide used as XA inhititor
06/26/2012US8207346 Methods of synthesizing anatabine
06/26/2012US8207344 GPR119 agonists
06/26/2012US8207331 Benzazepine derivatives for the treatment of neurological disorders
06/26/2012US8207202 N-(2-aminophenyl)-4-{1-[(5-methoxy-1,3-dimethyl-1H-pyrazol-4-yl)methyl]piperidin-4-yl}benzamide, for example; use as an antiproliferative agent in the prevention or treatment of tumors or other proliferative conditions, which are sensitive to the inhibition of histone deacetylase
06/26/2012US8207199 Azole compound
06/26/2012US8207198 Substituted triazole derivatives as oxytocin antagonists
06/26/2012US8207194 Compounds having a 4-pyridylalkylthio group as a substituent
06/26/2012US8207183 Inhibitors of IAP
06/26/2012US8207174 Beta-3 adrenergic receptor agonists; urinary tract infections, incontinence, gastrointestinal disorders, dysmenorrhea, obesity; tocolytic, anxiolytic, antidiabetic agents; antidepressants; 4-(2-hydroxy-3-(1-(5-phenylthieno[2,3-d]pyrimidin-4-yl)piperidin-4-ylamino)propoxy)phenol
06/26/2012US8207173 Benzimidazoles and analogs thereof as antivirals
06/26/2012US8207171 Cosmetic use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and related compounds
06/26/2012US8207168 Pyridazinone derivatives
06/26/2012US8207166 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
06/26/2012US8207155 Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disorders
06/26/2012US8207147 Heterocyclic derivatives as GPCR receptor agonists
06/26/2012CA2555804C Polymorphic form of imatinib mesylate and a process for its preparation
06/26/2012CA2511970C Urea derivatives useful in the treatment of heart failure
06/26/2012CA2504941C 3-substituted-6-aryl pyridines
06/26/2012CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
06/21/2012WO2012083246A1 Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
06/21/2012WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors
06/21/2012WO2012083058A2 Anti-viral compounds
06/21/2012WO2012083048A2 Anti-viral compounds
06/21/2012WO2012082972A1 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
06/21/2012WO2012082947A1 Compounds and compositions as tgr5 agonists
06/21/2012WO2012082746A2 Metalloenzyme inhibitor compounds
06/21/2012WO2012081736A1 Continuous arycyclic compound
06/21/2012WO2012081692A1 Pyrazole derivative
06/21/2012WO2012081665A1 Substance capable of inhibiting glycine transporter
06/21/2012WO2012081570A1 Lactam compound or a salt thereof, and ppar activator
06/21/2012WO2012081541A1 1, 2, 4, 5-substituted phenyl derivative, production method for same, and organic electroluminescent element
06/21/2012WO2012080288A1 4-aminoindole derivatives and use thereof for the oxidation dyeing of keratin fibres
06/21/2012WO2012080286A2 Dyeing composition comprising a heterocyclic oxidation base and a cationic 3,5-diaminopyridine coupler
06/21/2012WO2012080284A2 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
06/21/2012WO2012080271A1 Dimeric iap inhibitors
06/21/2012WO2012080260A1 Dimeric iap inhibitors
06/21/2012WO2012080233A1 Method for producing and purifying 3-aminopropanol
06/21/2012WO2012080115A1 Strigolactam derivatives and their use as plant growth regulators
06/21/2012WO2012079154A1 Selective estrogen receptor modulators
06/21/2012WO2012051213A3 Therapeutic 5,6,5-tricyclic analogs
06/21/2012WO2012050918A3 Tricyclic fused ring inhibitors of hepatitis c
06/21/2012WO2012044090A3 Novel aminoquinazoline compound having a protein-kinase inhibiting action
06/21/2012WO2012043996A3 Compound in which amine derivative is substituted with fluorene, organic electronic device using same, and terminal thereof
06/21/2012WO2012031090A9 Small molecule inhibitors of ebola and lassa fever viruses and methods of use
06/21/2012WO2012027623A3 Cyanine dyes
06/21/2012WO2011051540A9 Androgen receptor modulating compounds
06/21/2012US20120157681 Luminophores
06/21/2012US20120157680 Ionic liquid containing allylsulfonate anion
06/21/2012US20120157497 Compounds having analgesic and/or immunostimulant activity
06/21/2012US20120157494 Isoindolyl compounds
06/21/2012US20120157492 Antibiotic drug
06/21/2012US20120157488 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
06/21/2012US20120157484 Tryptophan hydroxylase inhibitors
06/21/2012US20120157471 Benzimidazole derivatives
06/21/2012US20120157466 Heterocyclic compounds with cxcr3 antagonist activity
06/21/2012US20120157464 Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives for the treatment or prevention of ataxia
06/21/2012US20120157462 Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
06/21/2012US20120157456 Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
06/21/2012US20120157454 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
06/21/2012US20120157447 Quinolone Carboxylic Acids, Derivatives Thereof, and Methods of Making and Using Same
06/21/2012US20120157443 Bruton's tyrosine kinase inhibitors
06/21/2012US20120157442 Heteroaryl btk inhibitors
06/21/2012US20120157440 Novel fused pyridine compounds as casein kinase inhibitors
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157433 Heteroaryl Compounds as Kinase Inhibitors
06/21/2012US20120157432 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120157429 Compounds useful as inhibitors of janus kinases
06/21/2012US20120157425 New compounds, pharmaceutical compositions and uses thereof
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157390 IAP Inhibitors
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157314 Novel substituted picolinic acids, salts and acid derivatives thereof, and use thereof as herbicides
06/21/2012US20120156508 Photochromic compounds and compositions
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 1080